Nasopharyngeal Cancinoma (NPC) Clinical Trials

42 clinical trials for Nasopharyngeal Cancinoma (NPC) across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• LDRT and Chemoimmunotherapy in NPC With Liver Metastasis — RECRUITING · PHASE2
• Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors — RECRUITING · PHASE1
• A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers — RECRUITING · PHASE1
• LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC — RECRUITING · PHASE2
• EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma — RECRUITING · PHASE1
• Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid — RECRUITING · PHASE3
• International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer — RECRUITING
• Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy — RECRUITING · PHASE2
• Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. — RECRUITING · PHASE3
• Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features — RECRUITING
• Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC — RECRUITING · PHASE3
• Adaptive Immunotherapy for Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy — RECRUITING
• Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy — RECRUITING · PHASE2
• SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy — RECRUITING · PHASE2
• QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. — RECRUITING · PHASE3
• Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI — RECRUITING
• A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC) — RECRUITING
• Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. — ACTIVE_NOT_RECRUITING · PHASE2
• Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · NA
• Application of Endoscopic Selective Neck Dissection Under Multimodal Assessment for Residual Cervical Lymph Nodes in N3 Nasopharyngeal Carcinoma After Radiotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE3
• MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial — NOT_YET_RECRUITING · PHASE2
• Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE3
• Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE3
• Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC — ACTIVE_NOT_RECRUITING · PHASE3
• Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial — ACTIVE_NOT_RECRUITING · NA
• Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE3
• Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE2
• EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE2
• Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE2
• Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity — NOT_YET_RECRUITING · PHASE3
• Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients — ACTIVE_NOT_RECRUITING · NA
• GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE2
• Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma — ACTIVE_NOT_RECRUITING
• TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China — COMPLETED

Refine this search